人間のSNPは,炎症性および感染性疾患における異なるアウトカムをFOXO3調節経路と関連付けています
James C Lee1, Marion Espéli, Carl A Anderson
1Cambridge Institute for Medical Research, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0XY, UK; Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
Cell
|September 17, 2013
まとめ
特定の遺伝子変異体 (rs12212067:Gアレル) は,感受性に影響を与えることなく,疾患の予後に影響を与えます. この遺伝因子は炎症反応を調節し,クローン病やリウマチ性関節炎などの疾患に影響を与えます.
科学分野:
- 遺伝学 遺伝学とは
- 免疫学 免疫学とは
- 複雑な病気 複雑な病気
背景:
- 疾患の予後は個々人によって大きく変化し,患者の治療結果に影響を及ぼします.
- この予後変動の遺伝的基盤は,依然としてほとんど未調査のままである.
- 全ゲノム関連研究 (GWAS) は,疾患の進行に対する遺伝的影響を調査するための強力なツールです.
研究 の 目的:
- 病気の予後を決定する遺伝因子の役割を調査する.
- 疾患のアウトカムに関連した特定の遺伝子変異を特定する.
- 遺伝的変異と疾患の進行を結びつける分子メカニズムを解明する.
主な方法:
- 既存の全ゲノム関連研究 (GWAS) データの分析.
- FOXO3A遺伝子における特定のノンコーディングポリモルフィズム (rs12212067:T > G) の識別と特徴付け.
- 単細胞における炎症反応に対するマイナーアレル (G) の機能的影響の調査.
主要な成果:
- rs12212067のマイナーアレル (G) は,疾患の感受性とは関係ありませんが,クローン病およびリウマチ性関節炎のより軽度の臨床経過と関連しています.
- このアレルは,重度のマラリアのリスクの増加とも関連しています.
- マイナーアレルの存在は,TGFβ1を含むFOXO3駆動経路を通じて単細胞の炎症反応を制限し,炎症誘発性サイトカイン (TNFαなど) を減少させ,抗炎症性サイトカイン (IL-10など) を増加させます.
結論:
- 異なる疾患における予後に対する共通の遺伝的貢献が特定されています.
- この貢献は,炎症反応を調節するFOXO3駆動経路を介して動作します.
- この発見は,病気のアウトカムを改善するための治療的介入のために,この経路をターゲットにする可能性を示しています.
関連する概念動画
Pleiotropy
31.3K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
31.3K
Exon Recombination
3.1K
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon...
Exon shuffling follows “splice frame rules.” Each exon...
3.1K
NF-κB-dependent Signaling Pathway
7.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.7K
Single Nucleotide Polymorphisms-SNPs
14.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.8K
The JAK-STAT Signaling Pathway
10.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
10.2K
Pharmacogenomics: Identification of New Drug Targets
129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129


